|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$2,073,304
|
N/A
|
(NCI)
|
|
|
Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer
|
1U01CA168870-01
|
$355,985
|
$355,985
|
ABBOTT, KAREN
|
UNIVERSITY OF GEORGIA (UGA)
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$3,750
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$7,192
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$197,691
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-43S1
|
$127,557
|
$15,307
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-43
|
$2,516,654
|
$301,998
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
5U01CA151452-03
|
$413,032
|
$206,516
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-03
|
$321,854
|
$64,371
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
|
SEER Special Studies
|
ZIA CP010183-10316
|
$57,766
|
$23,106
|
Anderson, Bill
|
DCEG (NCI)
|
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIABC011054
|
$578,627
|
$578,627
|
Annunziata, Christina
|
CCR (NCI)
|
|
|
Mechanisms of Chromosomal Translocation
|
ZIASC010379
|
$220,508
|
$44,102
|
Aplan, Peter
|
CCR (NCI)
|
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIABC011197
|
$461,568
|
$230,784
|
Appella, Ettore
|
CCR (NCI)
|
|
|
Biophotonics Noninvasive Detection of Ovarian Cancer
|
5R21CA156944-02
|
$316,438
|
$316,438
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
|
Southwest Oncology Group Biorepository
|
3U24CA114748-07S1
|
$697,714
|
$69,771
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Biorepository
|
5U24CA114748-07
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Dartmouth Center for Cancer Nanotechnology Excellence
|
5U54CA151662-03
|
$2,353,780
|
$776,747
|
Baker, Ian
|
DARTMOUTH COLLEGE
|
|
|
Obesity in ovarian cancer prognosis
|
5K22CA138563-03
|
$201,381
|
$201,381
|
BANDERA, ELISA
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
CD4+ Memory T-Cells in Human Tumor Microenvironment
|
5R01CA108970-08
|
$296,719
|
$296,719
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
|
Re-activating Memory T Cells in the Microenvironment of Human Tumors
|
5R01CA131407-05
|
$335,374
|
$335,374
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
|
Role of the Fractalkine Signaling in EOC
|
5R21CA160917-02
|
$168,249
|
$168,249
|
Barbolina, Maria
|
UNIVERSITY OF ILLINOIS
|
|
|
Improving Vaccinia for Peritoneal Tumors: Enhanced Distribution & Immune Evasion
|
5R01CA155925-02
|
$313,262
|
$103,376
|
BARTLETT, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-13
|
$2,227,276
|
$2,227,276
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-04
|
$306,953
|
$306,953
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$57,467
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
Splicing factors as therapeutic targets for the treatment of ovarian cancer
|
5R01CA138762-04
|
$307,810
|
$307,810
|
BECK, WILLIAM
|
UNIVERSITY OF ILLINOIS
|
|
|
Cancer Center Support Grant
|
3P30CA042014-23S1
|
$75,000
|
$750
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
|
Cancer Center Support Grant
|
5P30CA042014-23
|
$1,454,512
|
$14,545
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
|
Iowa Oncology Research Association
|
2U10CA035101-27
|
$669,579
|
$33,479
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$446,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$2,263
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-30S1
|
$50,000
|
$2,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-30S2
|
$75,000
|
$3,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-30
|
$2,547,570
|
$101,903
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-19
|
$543,533
|
$27,177
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
5K05CA136967-04
|
$137,885
|
$6,894
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Breast and Other Cancers in the California Teachers Cohort
|
5R01CA077398-14
|
$2,522,927
|
$252,293
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Bmi-1, a potential therapeutic target in ovarian cancer
|
1R01CA157481-01A1
|
$344,461
|
$344,461
|
Bhattacharya, Resham
|
MAYO CLINIC
|
|
|
JHU ICMIC Program
|
5P50CA103175-07
|
$1,442,883
|
$57,715
|
Bhujwalla, Zaver
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Racial Disparities, Survival & Secondary Debulking for Ovarian Cancer
|
5R01CA157176-02
|
$451,915
|
$451,915
|
BICKELL, NINA
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
|
Novel DNA-metalating Hybrid Anticancer Agents
|
5R01CA101880-08
|
$220,019
|
$22,002
|
Bierbach, Ulrich
|
WAKE FOREST UNIVERSITY
|
|
|
Novel Biomarkers in Ovarian Cancer
|
5R01CA142832-03
|
$347,562
|
$347,562
|
Birrer, Michael
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER
|
5U10CA037517-28
|
$4,570,599
|
$2,925,183
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Role of TbRIII in Regulating Motility and Invasion
|
5R01CA135006-04
|
$423,323
|
$211,662
|
BLOBE, GERARD
|
DUKE UNIVERSITY
|
|
|
The High Cost of Risk Reduction: Addressing Sexual Dysfunction after Oophorectomy
|
5R03CA153815-02
|
$87,500
|
$87,500
|
Bober, Sharon
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-07
|
$391,105
|
$129,065
|
BODURKA, DIANE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIABC011124
|
$276,834
|
$13,842
|
Bottaro, Donald
|
CCR (NCI)
|
|
Total relevant funding to Ovarian Cancer for this search: $111,657,265
|
